TMOD1
Tropomodulin-1
Also known as: D9S57E, ETMOD, TMOD, TMOD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28289
- Gene
- TMOD1
- Ensembl
- ENSG00000136842
- Chromosome
- 9
- Canonical length
- 359 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the tropomodulin family. The encoded protein is an actin-capping protein that regulates tropomyosin by binding to its N-terminus, inhibiting depolymerization and elongation of the pointed end of actin filaments and thereby influencing the structure of the erythrocyte membrane skeleton. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>P28289|TMOD1
1 MSYRRELEKY RDLDEDEILG ALTEEELRTL ENELDELDPD NALLPAGLRQ KDQTTKAPTG
61 PFKREELLDH LEKQAKEFKD REDLVPYTGE KRGKVWVPKQ KPLDPVLESV TLEPELEEAL
121 ANASDAELCD IAAILGMHTL MSNQQYYQAL SSSSIMNKEG LNSVIKPTQY KPVPDEEPNS
181 TDVEETLERI KNNDPKLEEV NLNNIRNIPI PTLKAYAEAL KENSYVKKFS IVGTRSNDPV
241 AYALAEMLKE NKVLKTLNVE SNFISGAGIL RLVEALPYNT SLVEMKIDNQ SQPLGNKVEM
301 EIVSMLEKNA TLLKFGYHFT QQGPRLRASN AMMNNNDLVR KRRLADLTGP IIPKCRSGVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMOD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 239 nTPM
Expression across tissuesHPA
Tissue
- tongue: 239 nTPM
- skeletal muscle: 234 nTPM
- heart muscle: 135 nTPM
- blood vessel: 73 nTPM
- adrenal gland: 62 nTPM
- ovary: 49 nTPM
Single-cell type
- adrenal medulla cells: 564 nCPM
- pancreatic islet cells: 406 nCPM
- pituitary stem cells: 327 nCPM
- retinal horizontal cells: 252 nCPM
- mast cells: 194 nCPM
- cardiomyocytes: 175 nCPM
Immune cell
- T-reg: 2.2 nTPM
- naive B-cell: 2 nTPM
- gdT-cell: 1.2 nTPM
- memory B-cell: 1.2 nTPM
- MAIT T-cell: 1.1 nTPM
- total PBMC: 1.1 nTPM
Brain region
- hypothalamus: 41 nTPM
- cerebellum: 38 nTPM
- white matter: 33 nTPM
- cerebral cortex: 31 nTPM
- medulla oblongata: 29 nTPM
- basal ganglia: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.48
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- adult locomotory behavior
- lens fiber cell development
- muscle contraction
- myofibril assembly
- pointed-end actin filament capping
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TMOD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMOD1 as an antibody target. Whether an autoantibody or antibody against TMOD1 could matter depends on whether native TMOD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMOD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMOD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...